Publication

Interleukin-6 Is an Early Plasma Marker of Severe Postoperative Complications in Thoracic Surgery: Exploratory Results From a Substudy of a Randomized Controlled Multicenter Trial.

Journal Paper/Review - Jan 1, 2022

Units
PubMed
Doi
Contact

Citation
Neff T, Braun J, Rana D, Puhan M, Filipovic M, Seeberger M, Stuber F, Neff S, Beck-Schimmer B, Schläpfer M. Interleukin-6 Is an Early Plasma Marker of Severe Postoperative Complications in Thoracic Surgery: Exploratory Results From a Substudy of a Randomized Controlled Multicenter Trial. Anesth Analg 2022; 134:123-132.
Type
Journal Paper/Review (English)
Journal
Anesth Analg 2022; 134
Publication Date
Jan 1, 2022
Issn Electronic
1526-7598
Pages
123-132
Brief description/objective

Postoperative complications in surgery are a significant burden, not only for the patients but also economically. While several predicting factors have already been identified, it is still not well known if increased levels of inflammatory markers in the immediate perioperative phase correlate with a higher incidence of postoperative complications. This study aimed to evaluate which patient characteristics and intraoperative parameters correlate with increased plasma values of monocyte chemoattractant protein 1 (MCP-1) and interleukin 6 (IL-6) of thoracic surgery patients. A second goal was to explore whether MCP-1 and IL-6 are associated with the incidence of postoperative complications. We hypothesized that there is a positive association between inflammatory markers and the occurrence of complications within 6 months after surgery.